GWI receives outstanding test results for Nattokinase

GWI receives outstanding test results for Nattokinase

Recent clinical and nonclinical studies show that the enzyme isolated from Natto, a traditional Japanese fermented soy food, supports heart health and promotes healthy circulation.

GWI announces outstanding test results for Nattokinase. Tested by Analytical Laboratories in Anaheim Inc., our product quality exceeded standard level 20000 FU/g by 62.9% with an active ingredient at 32580 FU/g. 

GWI is dedicated to being the leading provider of quality products, which is why we have established a six-step comprehensive quality assurance system. “At GWI, we understand how important product quality, GMP standards and corporate integrity are to our customers,” said Alice Chin, director of quality control. “Thus, meeting customer requirements and government regulations is the standard we stick to at all times.”

As “the Ingredients Superstore,” GWI keeps over 200 products in stock ready for immediate delivery, and we strive to update new products on a regular basis catering to the current market trend. Received increasing awareness among consumers, Nattokinase is an enzyme isolated from Natto, a traditional Japanese fermented soy food. Natto has been consumed safely for thousands of years for its health benefits, while Nattokinase can dissolve fibrin directly and enhances the production of clot-dissolving agent such as Urokinase t-PA.

More recently, both clinical and non-clinical studies have demonstrated that Nattokinase supports heart health and promotes healthy circulation. For additional information on Nattokinase, please contact GWI customer service department at 562.207.9770.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish